This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

The Promotion Plan of Moxibustion on Ulcerate Colitis

Sponsored by Shanghai Institute of Acupuncture, Moxibustion and Meridian

About this trial

Last updated 4 years ago

Study ID

promotion

Status

Completed

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18-75 Years
18 to 65 Years
All
All

Trial Timing

Ended 6 years ago

What is this trial about?

To evaluate the efficacy of Moxibustion in the treatment of Ulcerative Colitis, thus the scientific foundation for rational use of Moxibustion in clinical usage, in order to find admission of the Acupuncture and Moxibustion and even medicine field, accomplish popularization and application.

What are the participation requirements?

Yes

Inclusion Criteria

- Meet the diagnosis of UC

- Patients do not receive any medicine, or if they are receiving medicine, it should be aminosalicylates and/or prednisone (dose ≤15mg and have taken at least 1 month);

- Patients should have not received antibiotic, biologicals within 3 months prior to entering the study;

- Signing a written informed consent.

No

Exclusion Criteria

- Patients with cardiac, encephalic, hepatic, nephric, hematopoietic system, psychotic or any other serious diseases;

- Pregnancy or lactation;

- genetic family history of nervous system disease